Cargando…

Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial

INTRODUCTION: The aim of this work is to examine the efficacy and safety of prefilled liquid etanercept-biosimilar Yisaipu versus lyophilized Yisaipu in active ankylosing spondylitis (AS) patients. METHODS: This double-blind, phase III trial with non-inferiority design randomized adult patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Dongbao, He, Dongyi, Bi, Liqi, Wu, Huaxiang, Liu, Yi, Wu, Zhenbiao, Li, Yang, Wang, Guochun, Li, Xingfu, Bao, Chunde, Jiang, Lindi, Zhang, Zhiyi, Xiao, Weiguo, Tong, Gang, Wang, Dong, Huang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991065/ https://www.ncbi.nlm.nih.gov/pubmed/33559842 http://dx.doi.org/10.1007/s40744-021-00276-1

Ejemplares similares

Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points
por: Su, Jinmei, et al.
Publicado: (2020)

Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study
por: Zhang, Ting, et al.
Publicado: (2020)

Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study
por: Su, Jinmei, et al.
Publicado: (2021)

Infertility improved by etanercept in ankylosing spondylitis
por: Rezvani, Aylin, et al.
Publicado: (2008)

Treatment of ankylosing spondylitis: focus on etanercept
por: Frech, Tracy
Publicado: (2007)

Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
por: Su, Jinmei, et al.
Publicado: (2020)

Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
por: Raffeiner, Bernd, et al.
Publicado: (2014)

Relapsing Polychondritis in a Patient with Ankylosing Spondylitis Using Etanercept
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2014)

Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
por: Senabre-Gallego, José Miguel, et al.
Publicado: (2013)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes
por: von Richter, Oliver, et al.
Publicado: (2016)

Etanercept in the treatment of ankylosing spondylitis: A systematic review and meta-analysis
por: LIU, YA-FEI, et al.
Publicado: (2014)

Effects of etanercept and infliximab on bone metabolism indexes in patients with ankylosing spondylitis
por: Wang, Chenghai, et al.
Publicado: (2020)

Safety and Clinical Responses in Ankylosing Spondylitis after Three Months of Etanercept Therapy
por: Choi, Chan-Bum, et al.
Publicado: (2008)

Real‐life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
por: Kapoor, Sanjiv, et al.
Publicado: (2019)

GP2015: An Etanercept Biosimilar
por: Deeks, Emma D.
Publicado: (2017)

The Long-Term Effects of Short-Period Adalimumab Biosimilar Usage in Ankylosing Spondylitis
por: Chopra, Arvind, et al.
Publicado: (2023)

Two-year follow-up results after re-administration of etanercept in active ankylosing spondylitis
por: Baraliakos, X, et al.
Publicado: (2005)

Pustular eruption induced by etanercept in a patient with ankylosing spondylitis: a rare side effect
por: Kara, Asude, et al.
Publicado: (2015)

Pulmonary Sarcoidosis following Etanercept Treatment for Ankylosing Spondylitis: A Case Report and Review of the Literature
por: Majjad, A., et al.
Publicado: (2018)

Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini, Fabrizio, et al.
Publicado: (2018)

Correction to: GP2015: An Etanercept Biosimilar
por: Deeks, Emma D.
Publicado: (2018)

Successful Etanercept Therapy for Refractory Sacroiliitis in a Patient with Ankylosing Spondylitis and Mixed Connective Tissue Disease
por: Lee, Jee Young, et al.
Publicado: (2008)

Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report
por: Lee, Jong-Mok, et al.
Publicado: (2020)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population
por: Yan, Rui-Jian, et al.
Publicado: (2017)

Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
por: Baraliakos, Xenofon, et al.
Publicado: (2013)

Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients
por: Druce, Katie L., et al.
Publicado: (2018)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Andersson Lesion in Ankylosing Spondylitis
por: Wu, Xin, et al.
Publicado: (2022)

Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
por: Tong, Qiang, et al.
Publicado: (2015)

Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial
por: Tu, Liudan, et al.
Publicado: (2022)

Yisaipu(®) Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation
por: Lu, Hongjuan, et al.
Publicado: (2021)

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
por: Chadwick, Laura, et al.
Publicado: (2018)

Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar
por: Fazel, Ramin, et al.
Publicado: (2019)

Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
por: Shin, Donghoon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_53kl9l6p0ov1k2kmd3s2kofebq